Epigenetic and transcriptional modulation of WDR5, a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model

Simona Baronchelli, Alberto La Spada, Aikaterini Ntai, Andrea Barbieri, Paola Conforti, Gloria Saccani Jotti, Serena Redaelli, Angela Bentivegna, Pasquale De Blasio, Ida Biunno

Research output: Contribution to journalArticle

Abstract

DNA methylation (DNAm) changes are of increasing relevance to neurodegenerative disorders, including Huntington's disease (HD). We performed genome-wide screening of possible DNAm changes occurring during striatal differentiation in human induced pluripotent stem cells derived from a HD patient (HD-hiPSCs) as cellular model. We identified 240 differentially methylated regions (DMRs) at promoters in fully differentiated HD-hiPSCs. Subsequently, we focused on the methylation differences in a subcluster of genes related to Jumonji Domain Containing 3 (JMJD3), a demethylase that epigenetically regulates neuronal differentiation and activates neuronal progenitor associated genes, which are indispensable for neuronal fate acquisition. Noticeably among these genes, WD repeat-containing protein 5 (WDR5) promoter was found hypermethylated in HD-hiPSCs, resulting in a significant down-modulation in its expression and of the encoded protein. A similar WDR5 expression decrease was seen in a small series of HD-hiPSC lines characterized by different CAG length. The decrease in WDR5 expression was particularly evident in HD-hiPSCs compared to hESCs and control-hiPSCs from healthy subjects. WDR5 is a core component of the MLL/SET1 chromatin remodeling complexes essential for H3K4me3, previously reported to play an important role in stem cells self-renewal and differentiation. These results suggest the existence of epigenetic mechanisms in HD and the identification of genes, which are able to modulate HD phenotype, is important both for biomarker discovery and therapeutic interventions.

Original languageEnglish
Pages (from-to)46-57
Number of pages12
JournalMolecular and Cellular Neuroscience
Volume82
DOIs
Publication statusPublished - Jul 1 2017

Fingerprint

Induced Pluripotent Stem Cells
Chromatin Assembly and Disassembly
Huntington Disease
Epigenomics
Proteins
DNA Methylation
Genes
WD40 Repeats
Huntingtin Protein
Corpus Striatum
Genetic Promoter Regions
Neurodegenerative Diseases
Methylation
Healthy Volunteers
Biomarkers
Genome
Phenotype
Cell Line

Keywords

  • Chromatin remodeling
  • Disease modifying genes
  • DNA methylation
  • Human induced pluripotent stem cells (hiPSCs)
  • Huntington's disease

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

Epigenetic and transcriptional modulation of WDR5, a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model. / Baronchelli, Simona; La Spada, Alberto; Ntai, Aikaterini; Barbieri, Andrea; Conforti, Paola; Jotti, Gloria Saccani; Redaelli, Serena; Bentivegna, Angela; De Blasio, Pasquale; Biunno, Ida.

In: Molecular and Cellular Neuroscience, Vol. 82, 01.07.2017, p. 46-57.

Research output: Contribution to journalArticle

Baronchelli, S, La Spada, A, Ntai, A, Barbieri, A, Conforti, P, Jotti, GS, Redaelli, S, Bentivegna, A, De Blasio, P & Biunno, I 2017, 'Epigenetic and transcriptional modulation of WDR5, a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model', Molecular and Cellular Neuroscience, vol. 82, pp. 46-57. https://doi.org/10.1016/j.mcn.2017.04.013
Baronchelli, Simona ; La Spada, Alberto ; Ntai, Aikaterini ; Barbieri, Andrea ; Conforti, Paola ; Jotti, Gloria Saccani ; Redaelli, Serena ; Bentivegna, Angela ; De Blasio, Pasquale ; Biunno, Ida. / Epigenetic and transcriptional modulation of WDR5, a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model. In: Molecular and Cellular Neuroscience. 2017 ; Vol. 82. pp. 46-57.
@article{01cd9744b9ac49f39d45c8fc3cf30625,
title = "Epigenetic and transcriptional modulation of WDR5, a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model",
abstract = "DNA methylation (DNAm) changes are of increasing relevance to neurodegenerative disorders, including Huntington's disease (HD). We performed genome-wide screening of possible DNAm changes occurring during striatal differentiation in human induced pluripotent stem cells derived from a HD patient (HD-hiPSCs) as cellular model. We identified 240 differentially methylated regions (DMRs) at promoters in fully differentiated HD-hiPSCs. Subsequently, we focused on the methylation differences in a subcluster of genes related to Jumonji Domain Containing 3 (JMJD3), a demethylase that epigenetically regulates neuronal differentiation and activates neuronal progenitor associated genes, which are indispensable for neuronal fate acquisition. Noticeably among these genes, WD repeat-containing protein 5 (WDR5) promoter was found hypermethylated in HD-hiPSCs, resulting in a significant down-modulation in its expression and of the encoded protein. A similar WDR5 expression decrease was seen in a small series of HD-hiPSC lines characterized by different CAG length. The decrease in WDR5 expression was particularly evident in HD-hiPSCs compared to hESCs and control-hiPSCs from healthy subjects. WDR5 is a core component of the MLL/SET1 chromatin remodeling complexes essential for H3K4me3, previously reported to play an important role in stem cells self-renewal and differentiation. These results suggest the existence of epigenetic mechanisms in HD and the identification of genes, which are able to modulate HD phenotype, is important both for biomarker discovery and therapeutic interventions.",
keywords = "Chromatin remodeling, Disease modifying genes, DNA methylation, Human induced pluripotent stem cells (hiPSCs), Huntington's disease",
author = "Simona Baronchelli and {La Spada}, Alberto and Aikaterini Ntai and Andrea Barbieri and Paola Conforti and Jotti, {Gloria Saccani} and Serena Redaelli and Angela Bentivegna and {De Blasio}, Pasquale and Ida Biunno",
year = "2017",
month = "7",
day = "1",
doi = "10.1016/j.mcn.2017.04.013",
language = "English",
volume = "82",
pages = "46--57",
journal = "Molecular and Cellular Neurosciences",
issn = "1044-7431",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Epigenetic and transcriptional modulation of WDR5, a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model

AU - Baronchelli, Simona

AU - La Spada, Alberto

AU - Ntai, Aikaterini

AU - Barbieri, Andrea

AU - Conforti, Paola

AU - Jotti, Gloria Saccani

AU - Redaelli, Serena

AU - Bentivegna, Angela

AU - De Blasio, Pasquale

AU - Biunno, Ida

PY - 2017/7/1

Y1 - 2017/7/1

N2 - DNA methylation (DNAm) changes are of increasing relevance to neurodegenerative disorders, including Huntington's disease (HD). We performed genome-wide screening of possible DNAm changes occurring during striatal differentiation in human induced pluripotent stem cells derived from a HD patient (HD-hiPSCs) as cellular model. We identified 240 differentially methylated regions (DMRs) at promoters in fully differentiated HD-hiPSCs. Subsequently, we focused on the methylation differences in a subcluster of genes related to Jumonji Domain Containing 3 (JMJD3), a demethylase that epigenetically regulates neuronal differentiation and activates neuronal progenitor associated genes, which are indispensable for neuronal fate acquisition. Noticeably among these genes, WD repeat-containing protein 5 (WDR5) promoter was found hypermethylated in HD-hiPSCs, resulting in a significant down-modulation in its expression and of the encoded protein. A similar WDR5 expression decrease was seen in a small series of HD-hiPSC lines characterized by different CAG length. The decrease in WDR5 expression was particularly evident in HD-hiPSCs compared to hESCs and control-hiPSCs from healthy subjects. WDR5 is a core component of the MLL/SET1 chromatin remodeling complexes essential for H3K4me3, previously reported to play an important role in stem cells self-renewal and differentiation. These results suggest the existence of epigenetic mechanisms in HD and the identification of genes, which are able to modulate HD phenotype, is important both for biomarker discovery and therapeutic interventions.

AB - DNA methylation (DNAm) changes are of increasing relevance to neurodegenerative disorders, including Huntington's disease (HD). We performed genome-wide screening of possible DNAm changes occurring during striatal differentiation in human induced pluripotent stem cells derived from a HD patient (HD-hiPSCs) as cellular model. We identified 240 differentially methylated regions (DMRs) at promoters in fully differentiated HD-hiPSCs. Subsequently, we focused on the methylation differences in a subcluster of genes related to Jumonji Domain Containing 3 (JMJD3), a demethylase that epigenetically regulates neuronal differentiation and activates neuronal progenitor associated genes, which are indispensable for neuronal fate acquisition. Noticeably among these genes, WD repeat-containing protein 5 (WDR5) promoter was found hypermethylated in HD-hiPSCs, resulting in a significant down-modulation in its expression and of the encoded protein. A similar WDR5 expression decrease was seen in a small series of HD-hiPSC lines characterized by different CAG length. The decrease in WDR5 expression was particularly evident in HD-hiPSCs compared to hESCs and control-hiPSCs from healthy subjects. WDR5 is a core component of the MLL/SET1 chromatin remodeling complexes essential for H3K4me3, previously reported to play an important role in stem cells self-renewal and differentiation. These results suggest the existence of epigenetic mechanisms in HD and the identification of genes, which are able to modulate HD phenotype, is important both for biomarker discovery and therapeutic interventions.

KW - Chromatin remodeling

KW - Disease modifying genes

KW - DNA methylation

KW - Human induced pluripotent stem cells (hiPSCs)

KW - Huntington's disease

UR - http://www.scopus.com/inward/record.url?scp=85018779628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018779628&partnerID=8YFLogxK

U2 - 10.1016/j.mcn.2017.04.013

DO - 10.1016/j.mcn.2017.04.013

M3 - Article

VL - 82

SP - 46

EP - 57

JO - Molecular and Cellular Neurosciences

JF - Molecular and Cellular Neurosciences

SN - 1044-7431

ER -